Safety and efficacy of restarting antiplatelet therapy after intracerebral hemorrhage
- PMID: 31656797
- PMCID: PMC6789309
- DOI: 10.21037/atm.2019.08.96
Safety and efficacy of restarting antiplatelet therapy after intracerebral hemorrhage
Conflict of interest statement
Conflicts of Interest: The authors have no conflicts of interest to declare.
Comment on
-
Effects of antiplatelet therapy after stroke due to intracerebral haemorrhage (RESTART): a randomised, open-label trial.Lancet. 2019 Jun 29;393(10191):2613-2623. doi: 10.1016/S0140-6736(19)30840-2. Epub 2019 May 22. Lancet. 2019. PMID: 31128924 Free PMC article. Clinical Trial.
References
Publication types
LinkOut - more resources
Full Text Sources